Aethlon Medical (AEMD)
1.89
-0.02 (1.05%)
Upcoming Events
Latest Headlines
Form S-8 AETHLON MEDICAL INC
June 10, 2026 5:15 PM - SEC Filing
Form 10-K AETHLON MEDICAL INC For: Mar 31
June 10, 2026 5:11 PM - SEC Filing
Form 8-K AETHLON MEDICAL INC For: Jun 10
June 10, 2026 4:16 PM - SEC Filing
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
June 10, 2026 4:15 PM - PR NewsWire
Form 424B5 AETHLON MEDICAL INC
June 4, 2026 9:00 AM - SEC Filing
Form 8-K AETHLON MEDICAL INC For: Jun 04
June 4, 2026 9:00 AM - SEC Filing
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
June 2, 2026 8:01 AM - PR NewsWire
Aethlon Medical monitors Ebola outbreak, cites device preparedness
May 21, 2026 8:02 AM - StreetInsider
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
May 21, 2026 8:01 AM - PR NewsWire
Form SCHEDULE 13G/A AETHLON MEDICAL INC Filed by: ARMISTICE CAPITAL, LLC
May 15, 2026 11:01 AM - SEC Filing
Form 4 AETHLON MEDICAL INC For: Apr 17 Filed by: Rossetti Angela
April 21, 2026 5:00 PM - SEC Filing
Form 4 AETHLON MEDICAL INC For: Apr 17 Filed by: Shah Chetan
April 21, 2026 5:00 PM - SEC Filing
Form 4 AETHLON MEDICAL INC For: Apr 17 Filed by: BROENNIMAN EDWARD G
April 21, 2026 5:00 PM - SEC Filing
Form 4 AETHLON MEDICAL INC For: Apr 17 Filed by: Gikakis Nicolas
April 21, 2026 5:00 PM - SEC Filing
Form 4 AETHLON MEDICAL INC For: Mar 31 Filed by: Shah Chetan
April 1, 2026 7:28 PM - SEC Filing
Form 4 AETHLON MEDICAL INC For: Mar 31 Filed by: Gikakis Nicolas
April 1, 2026 7:28 PM - SEC Filing
Form 4 AETHLON MEDICAL INC For: Mar 31 Filed by: BROENNIMAN EDWARD G
April 1, 2026 7:27 PM - SEC Filing
Presenting on Emerging Growth Conference 91 Day 2 on April 2; Register to live stream
April 1, 2026 7:00 AM - Globe NewsWire
Advancements in Novel Immunotherapeutics in The Oncology Battle
March 24, 2026 10:32 AM - StreetInsider
Aethlon Medical advances to final trial cohort after safety review
March 24, 2026 8:01 AM - StreetInsider
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
March 24, 2026 8:01 AM - PR NewsWire
Full Article List